Characterization of Non-Nitrocatechol Pan and Isoform Specific Catechol-O-methyltransferase Inhibitors and Substrates

详细信息    查看全文

• 作者：Ronald G. Robinson ; Sean M. Smith ; Scott E. Wolkenberg ; Monika Kandebo ; Lihang Yao ; Christopher R. Gibson ; Scott T. Harrison ; Stacey Polsky-Fisher ; James C. Barrow ; Peter J. Manley ; James J. Mulhearn ; Kausik K. Nanda ; Jeffrey W. Schubert ; B. Wesley Trotter ; Zhijian Zhao ; John M. Sanders ; Robert F. Smith ; Debra McLoughlin ; Sujata Sharma ; Dawn L. Hall ; Tiffany L. Walker ; Jennifer L. Kershner ; Neetesh Bhandari ; Pete H. Hutson ; Nancy A. Sachs
• 刊名：ACS Chemical Neuroscience
• 出版年：2012
• 出版时间：February 15, 2012
• 年：2012
• 卷：3
• 期：2
• 页码：129-140
• 全文大小：456K
• 年卷期：v.3,no.2(February 15, 2012)
• ISSN：1948-7193

文摘

Reduced dopamine neurotransmission in the prefrontal cortex has been implicated as causal for the negative symptoms and cognitive deficit associated with schizophrenia; thus, a compound which selectively enhances dopamine neurotransmission in the prefrontal cortex may have therapeutic potential. Inhibition of catechol-O-methyltransferase (COMT, EC 2.1.1.6) offers a unique advantage, since this enzyme is the primary mechanism for the elimination of dopamine in cortical areas. Since membrane bound COMT (MB-COMT) is the predominant isoform in human brain, a high throughput screen (HTS) to identify novel MB-COMT specific inhibitors was completed. Subsequent optimization led to the identification of novel, non-nitrocatechol COMT inhibitors, some of which interact specifically with MB-COMT. Compounds were characterized for in vitro efficacy versus human and rat MB and soluble (S)-COMT. Select compounds were administered to male Wistar rats, and ex vivo COMT activity, compound levels in plasma and cerebrospinal fluid (CSF), and CSF dopamine metabolite levels were determined as measures of preclinical efficacy. Finally, novel non-nitrocatechol COMT inhibitors displayed less potent uncoupling of the mitochondrial membrane potential (MMP) compared to tolcapone as well as nonhepatotoxic entacapone, thus mitigating the risk of hepatotoxicity.

Keywords:

Catechol-O-methyltransferase; high throughput screen; dihydroxyphenylacetic acid; homovanillic acid; fluorescence polarization and hepatotoxicity